MVMDF (Mountain Valley MD Holdings) Moat Score: 2/10 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mountain Valley MD Holdings Moat Score?

Mountain Valley MD Holdings MVMDF +3.64% Moat Score is 2 as of Aug. 01, 2026. The stock has 3 warning signs investors should review. Among 1,029 Drug Manufacturers companies, Mountain Valley MD Holdings ranks better than 81.63% on this metric.

Mountain Valley MD Holdings has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Mountain Valley MD Holdings has No Moat: Mountain Valley MD Holdings lacks significant market leadership or proprietary technology. It operates in a competitive industry with low barriers to entry, resulting in minimal durable cost advantages or pricing power.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Mountain Valley MD Holdings might have No Moat - Very weak/transient advantages.

Mountain Valley MD Holdings  (OTCPK:MVMDF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Mountain Valley MD Holdings Moat Score Related Terms

MVMDF vs ZTS: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mountain Valley MD Holdings Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where Mountain Valley MD Holdings's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Mountain Valley MD Holdings (MVMDF) has a Moat Score of 2 as of Aug. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Mountain Valley MD Holdings ranks #189 out of 1029 companies in the Drug Manufacturers industry, placing it in the top 18.4%.
Is Mountain Valley MD Holdings' Moat Score too high?
Mountain Valley MD Holdings' current Moat Score is 2. Based on the distribution chart, Mountain Valley MD Holdings ranks #189 out of 1029 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Mountain Valley MD Holdings' Moat Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mountain Valley MD Holdings ranks #189 out of 1029 companies for Moat Score. This places Mountain Valley MD Holdings in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Mountain Valley MD Holdings's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mountain Valley MD Holdings stock overvalued right now?
Mountain Valley MD Holdings (MVMDF) has a current Moat Score of 2. The current Moat Score is 2. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Mountain Valley MD Holdings (MVMDF), the current Moat Score is 2 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mountain Valley MD Holdings Business Description

Other Exchanges 20MP:GermanyMVMD:Canada
Address 260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm, along with its subsidiaries, is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The company actively invests in and collaborates on pioneering biotechnologies that have the potential to revolutionize the human health and wellness landscape, drive sustainable increases in plant yields and agricultural farming practices, and broadly support animal husbandry health. The Company is a biotech company focused on advancing solutions to optimize human, animal, and plant health.